Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas
- PMID: 2573419
Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas
Abstract
Four of 51 primary gastric carcinomas exhibited amplification of the erbB-2 protooncogene ranging from 2- to 8-fold. In three cases gene amplification affected erbB-2 alleles of normal gene structure as determined by Southern blot analysis. In addition, one tumor displayed gene amplification of an apparently rearranged erbB-2 allele. Analysis of the rearranged allele revealed a structural alteration consistent with an internal deletion of approximately 2 kilobase pairs within the erbB-2 gene. Quantitation of erbB-2 mRNA in these tumors demonstrated that gene amplification coincided with overexpression of erbB-2 mRNA ranging from 8- to 32-fold above levels observed in stomach tumors without gene amplification. Furthermore, in one of the tumors with amplified normal size erbB-2 restriction fragments, elevated erbB-2 mRNA levels consisted of the normal size 5-kilobase transcript. Thus, overexpression of normal size erbB-2 mRNA accompanies gene amplification in primary stomach tumors. In addition, evidence for erbB-2 gene rearrangement suggests a role for such alteration in the development of certain gastric carcinomas.
Similar articles
-
Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.Oncogene Res. 1988;3(1):21-31. Oncogene Res. 1988. PMID: 2905033
-
Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.Cancer Res. 1989 Dec 1;49(23):6675-9. Cancer Res. 1989. PMID: 2573420
-
Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.Anticancer Res. 1993 Sep-Oct;13(5A):1293-301. Anticancer Res. 1993. PMID: 7902061
-
Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.Semin Cancer Biol. 1993 Feb;4(1):19-26. Semin Cancer Biol. 1993. PMID: 8095411 Review.
-
c-erbB2 amplification and overexpression in human tumors.Cancer Treat Res. 1992;61:161-79. Cancer Treat Res. 1992. PMID: 1360230 Review.
Cited by
-
DNA amplifications and elevated expression of proto-oncogene in addition to altered DNA ploidy in metastatic brain tumors.Clin Exp Metastasis. 1994 Jul;12(4):267-75. doi: 10.1007/BF01753833. Clin Exp Metastasis. 1994. PMID: 7913669
-
Genomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization.PLoS One. 2011;6(7):e22313. doi: 10.1371/journal.pone.0022313. Epub 2011 Jul 21. PLoS One. 2011. PMID: 21811585 Free PMC article.
-
Infrequent alterations of the APC and MCC genes in gastric cancers from British patients.Br J Cancer. 1996 Oct;74(7):1104-8. doi: 10.1038/bjc.1996.497. Br J Cancer. 1996. PMID: 8855982 Free PMC article.
-
Amplification and overexpression of the c-erbB-2 protooncogene in human gastric cancer.Gastroenterol Jpn. 1992 Apr;27(2):172-8. doi: 10.1007/BF02777719. Gastroenterol Jpn. 1992. PMID: 1577221
-
Current development of molecular classifications of gastric cancer based on omics (Review).Int J Oncol. 2024 Sep;65(3):89. doi: 10.3892/ijo.2024.5677. Epub 2024 Aug 2. Int J Oncol. 2024. PMID: 39092559 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous